Works by Irving, William L.

Results: 40
    1
    2

    Recombinant Human L-Ficolin Directly Neutralizes Hepatitis C Virus Entry.

    Published in:
    Journal of Innate Immunity, 2014, v. 6, n. 5, p. 676, doi. 10.1159/000362209
    By:
    • Hamed, Mohamed R.;
    • Brown, Richard J.P.;
    • Zothner, Carsten;
    • Urbanowicz, Richard a.;
    • Mason, Christopher P.;
    • Krarup, anders;
    • McClure, C. Patrick;
    • Irving, William L.;
    • Ball, Jonathan K.;
    • Harris, Mark;
    • Hickling, Timothy P.;
    • Tarr, alexander W.
    Publication type:
    Article
    3
    4

    Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25649-6
    By:
    • Smith, David A.;
    • Fernandez-Antunez, Carlota;
    • Magri, Andrea;
    • Bowden, Rory;
    • Chaturvedi, Nimisha;
    • Fellay, Jacques;
    • McLauchlan, John;
    • Foster, Graham R.;
    • Irving, William L.;
    • STOP-HCV Consortium;
    • Ball, Jonathan;
    • Brainard, Diana;
    • Burgess, Gary;
    • Cooke, Graham;
    • Dillon, John;
    • Gore, Charles;
    • Guha, Neil;
    • Halford, Rachel;
    • Herath, Cham;
    • Holmes, Chris
    Publication type:
    Article
    5
    6
    7

    IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study.

    Published in:
    PLoS Medicine, 2011, v. 8, n. 9, p. 1
    By:
    • Suppiah, Vijayaprakash;
    • Gaudieri, Silvana;
    • Armstrong, Nicola J.;
    • O'Connor, Kate S.;
    • Berg, Thomas;
    • Weltman, Martin;
    • Abate, Maria Lorena;
    • Spengler, Ulrich;
    • Bassendine, Margaret;
    • Dore, Gregory J.;
    • Irving, William L.;
    • Powell, Elizabeth;
    • Hellard, Margaret;
    • Riordan, Stephen;
    • Matthews, Gail;
    • Sheridan, David;
    • Nattermann, Jacob;
    • Smedile, Antonina;
    • Müller, Tobias;
    • Hammond, Emma
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy.

    Published in:
    Journal of Viral Hepatitis, 2021, v. 28, n. 9, p. 1256, doi. 10.1111/jvh.13549
    By:
    • Smith, David A.;
    • Bradshaw, Daniel;
    • Mbisa, Jean L;
    • Manso, Carmen F.;
    • Bibby, David F;
    • Singer, Joshua B;
    • Thomson, Emma C;
    • da Silva Filipe, Ana;
    • Aranday‐Cortes, Elihu;
    • Ansari, M. Azim;
    • Brown, Anthony;
    • Hudson, Emma;
    • Benselin, Jennifer;
    • Healy, Brendan;
    • Troke, Phil;
    • McLauchlan, John;
    • Barnes, Eleanor;
    • Irving, William L.
    Publication type:
    Article
    14

    Impact of direct‐acting antiviral agents on liver function in patients with chronic hepatitis C virus infection.

    Published in:
    Journal of Viral Hepatitis, 2021, v. 28, n. 1, p. 168, doi. 10.1111/jvh.13408
    By:
    • Johnson, Philip J.;
    • Berhane, Sarah;
    • Walker, Alex J.;
    • Gordon, Fiona H.;
    • Ryder, Steven D;
    • McPherson, Stuart;
    • Sreedharan, Aravamuthan;
    • Ustianowski, Andrew A.;
    • Agarwal, Kosh;
    • Mutimer, David;
    • Kumada, Takeshi;
    • Toyoda, Hidenori;
    • Irving, William L.;
    • Agarwal, K.;
    • Aldersley, M.;
    • Ala, A.;
    • Aspinall, R.;
    • Barnes, E.;
    • Brown, A.;
    • Corless, L.
    Publication type:
    Article
    15
    16

    SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.

    Published in:
    EMBO Molecular Medicine, 2017, v. 9, n. 12, p. 1696, doi. 10.15252/emmm.201707860
    By:
    • Athwal, Varinder S;
    • Pritchett, James;
    • Llewellyn, Jessica;
    • Martin, Katherine;
    • Camacho, Elizabeth;
    • Raza, Sayyid MA;
    • Phythian‐Adams, Alexander;
    • Birchall, Lindsay J;
    • Mullan, Aoibheann F;
    • Su, Kim;
    • Pearmain, Laurence;
    • Dolman, Grace;
    • Zaitoun, Abed M;
    • Friedman, Scott L;
    • MacDonald, Andrew;
    • Irving, William L;
    • Guha, Indra N;
    • Hanley, Neil A;
    • Piper Hanley, Karen
    Publication type:
    Article
    17

    Viruses and cancer.

    Published in:
    International Journal of Experimental Pathology, 2001, v. 82, n. 1, p. 1, doi. 10.1046/j.1365-2613.2001.00187.x
    By:
    • Irving, William L.;
    • Thomson, Brian J.
    Publication type:
    Article
    18

    A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms.

    Published in:
    Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-35736-2
    By:
    • Sharkawy, Rasha El;
    • Bayoumi, Ali;
    • Metwally, Mayada;
    • Mangia, Alessandra;
    • Berg, Thomas;
    • Romero-Gomez, Manuel;
    • Abate, Maria Lorena;
    • Irving, William L.;
    • Sheridan, David;
    • Dore, Gregory J.;
    • Spengler, Ulrich;
    • Lampertico, Pietro;
    • Bugianesi, Elisabetta;
    • Weltman, Martin;
    • Mollison, Lindsay;
    • Cheng, Wendy;
    • Riordan, Stephen;
    • Santoro, Rosanna;
    • Gallego-Durán, Rocío;
    • Fischer, Janett
    Publication type:
    Article
    19
    20

    MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.

    Published in:
    Nature Communications, 2016, v. 7, n. 9, p. 12757, doi. 10.1038/ncomms12757
    By:
    • Thabet, Khaled;
    • Asimakopoulos, Anastasia;
    • Shojaei, Maryam;
    • Romero-Gomez, Manuel;
    • Mangia, Alessandra;
    • Irving, William L.;
    • Berg, Thomas;
    • Dore, Gregory J.;
    • Grønbæk, Henning;
    • Sheridan, David;
    • Abate, Maria Lorena;
    • Bugianesi, Elisabetta;
    • Weltman, Martin;
    • Mollison, Lindsay;
    • Cheng, Wendy;
    • Riordan, Stephen;
    • Fischer, Janett;
    • Spengler, Ulrich;
    • Nattermann, Jacob;
    • Wahid, Ahmed
    Publication type:
    Article
    21

    Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.

    Published in:
    Nature Communications, 2015, v. 6, n. 3, p. 6422, doi. 10.1038/ncomms7422
    By:
    • Eslam, Mohammed;
    • Hashem, Ahmed M.;
    • Leung, Reynold;
    • Romero-Gomez, Manuel;
    • Berg, Thomas;
    • Dore, Gregory J.;
    • Chan, Henry L.K.;
    • Irving, William L.;
    • Sheridan, David;
    • Abate, Maria L.;
    • Adams, Leon A.;
    • Mangia, Alessandra;
    • Weltman, Martin;
    • Bugianesi, Elisabetta;
    • Spengler, Ulrich;
    • Shaker, Olfat;
    • Fischer, Janett;
    • Mollison, Lindsay;
    • Cheng, Wendy;
    • Powell, Elizabeth
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Real-World Outcomes of Direct-Acting Antiviral Treatment and Retreatment in United Kingdom-Based Patients Infected With Hepatitis C Virus Genotypes/Subtypes Endemic in Africa.

    Published in:
    2022
    By:
    • Aranday-Cortes, Elihu;
    • McClure, C Patrick;
    • Davis, Christopher;
    • Irving, William L;
    • Adeboyejo, Kazeem;
    • Tong, Lily;
    • Filipe, Ana da Silva;
    • Sreenu, Vattipally;
    • Agarwal, Kosh;
    • Mutimer, David;
    • Stone, Benjamin;
    • Cramp, Matthew E;
    • Thomson, Emma C;
    • Ball, Jonathan K;
    • McLauchlan, John;
    • da Silva Filipe, Ana
    Publication type:
    journal article
    32

    Serum Levels of Proinflammatory Lipid Mediators and Specialized Proresolving Molecules Are Increased in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 and Correlate With Markers of the Adaptive Immune Response.

    Published in:
    Journal of Infectious Diseases, 2022, v. 225, n. 12, p. 2142, doi. 10.1093/infdis/jiab632
    By:
    • Turnbull, James;
    • Jha, Rakesh R;
    • Ortori, Catherine A;
    • Lunt, Eleanor;
    • Tighe, Patrick J;
    • Irving, William L;
    • Gohir, Sameer A;
    • Kim, Dong-Hyun;
    • Valdes, Ana M;
    • Tarr, Alexander W;
    • Barrett, David A;
    • Chapman, Victoria
    Publication type:
    Article
    33

    The Impact of Real-Time Whole-Genome Sequencing in Controlling Healthcare-Associated SARS-CoV-2 Outbreaks.

    Published in:
    Journal of Infectious Diseases, 2022, v. 225, n. 1, p. 10, doi. 10.1093/infdis/jiab483
    By:
    • Francis, Rodric V;
    • Billam, Harriet;
    • Clarke, Mitch;
    • Yates, Carl;
    • Tsoleridis, Theocharis;
    • Berry, Louise;
    • Mahida, Nikunj;
    • Irving, William L;
    • Moore, Christopher;
    • Holmes, Nadine;
    • Ball, Jonathan K;
    • Loose, Matthew;
    • McClure, C Patrick;
    • consortium, COVID-19 Genomics UK (COG-UK);
    • COVID-19 Genomics UK (COG-UK) consortium
    Publication type:
    Article
    34
    35
    36
    37

    Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis.

    Published in:
    Clinical & Translational Gastroenterology, 2022, v. 13, n. 3, p. e00462, doi. 10.14309/ctg.0000000000000462
    By:
    • Innes, Hamish;
    • Walker, Alex J.;
    • Benselin, Jennifer;
    • Grove, Jane I.;
    • Pedergnana, Vincent;
    • Azim Ansari, M.;
    • Lin, Shang-Kuan;
    • McLauchlan, John;
    • Hutchinson, Sharon J.;
    • Barnes, Eleanor;
    • Irving, William L.;
    • Guha, Indra Neil
    Publication type:
    Article
    38
    39
    40